Frankfurt/Main – Nasdaq-listed Bruker Corporation has announced a strategic investment in NovAliX, a preclinical Contract Research Organisation (CRO) specialising in drug discovery services that is headquartered in Strasbourg, France. The NovAliX Group has subsidiaries in countries including France, Belgium, Spain, the US, Tunisia and Japan. Bruker’s aim in making this investment is to accelerate the growth and further expansion of NovAliX, particularly within Europe and the United States. Bruker and NovAliX intend to collaborate on developing new paradigms in drug discovery by leveraging advanced biophysical methods, particularly NMR, for structural, binding and functional characterisation. The transaction is a milestone in Bruker’s strategy of expanding its position as a partner for high-quality services in the life sciences field.
An international CMS team headed by partner Dr Hendrik Hirsch and counsel Dr Berrit Roth-Mingram advised Bruker on all legal aspects of the transaction. Bruker is a longstanding CMS client. The US company regularly relies on the expertise of CMS when making acquisitions and disposals. The current instruction demonstrates once again the successful international collaboration of the CMS offices. In this case, CMS offices in France, Belgium and Spain were involved. Most recently, a large international team led by CMS partner Dr Hendrik Hirsch advised Bruker on its acquisition of the ELITech Group.
CMS Germany
Dr Hendrik Hirsch, Partner, Co-Lead
Dr Berrit Roth-Mingram, Counsel, Co-Lead
Martina Meier-Grom, Counsel
Dr Maximilian Stark, Senior Associate, all Corporate/M&A
Dr Thomas Hirse, Partner
Dr Roland Wiring, Partner
Thomas Fröhlich, Counsel
Dr Siham Hidar, Senior Associate
Lisa Dietrich, Associate
Noah Rodenkirchen, Associate, all IP
Dr Michael Bauer, Partner
Kai Neuhaus, Partner
Moritz Pottek, Counsel
David Rappenglück, Associate
Benedikt Christian Voss, Associate, all Antitrust, Competition & Trade
Till Komma, Counsel, Banking, Finance & Insurance
CMS France
Benoît Gomel, Partner
François Bossé-Cohic, Counsel
Caroline Buyse, Counsel
Dylan Allali, Associate
Vincent Desbenoit, Associate
Antoine Melchior, Associate, all Corporate/M&A
Alexandre Chazot, Counsel
Alexis Imbert, both Banking & Finance
Arnaud Valverde, Senior Associate
Alizée Fabre-Betti, Associate, both Real Estate
Jean-Baptiste Thiénot, Partner
Anaïs Arnal, Associate
Solenne Mignot, Lawyer, all IP
Caroline Froger-Michon, Partner
Florence Duprat-Cerri, Counsel
Camille Baumgarten, Associate
Sophie Yin, Lawyer, all Employment
Claire Vannini, Partner
Lilia-Oriana Dif, Associate
Guillaume Melot, Associate, all Competition
Myriam El Andaloussi, Associate
Paul Letartre, Associate, both TMC
Olivier Kuhn, Partner, Dispute Resolution
CMS Belgium
Stéphane Collin, Partner
Arnaud Van Oekel, Partner
Candice Kunkera, Senior Associate
Lola Verelst, Associate, all Corporate/M&A
Gaël Chuffart, Partner
Fatma Ezzahra Sassi, Associate, both Employment
Bruno Fonteyn, Senior Associate, Public
CMS Spain
Elena Alcázar Cuartero, Counsel
Alejandra Martín Benítez, Associate, both Corporate/M&A
Anna De las Cuevas, Associate
Guillermo García Diéguez, Associate
Francisco Javier Fernández Ródriguez, Lawyer, all Employment
Ana Doval Escribá de Romaní, Associate, Public
Sol Cruz-Conde de la Moneda, Lawyer, Banking & Finance
Press Contact
presse@cms-hs.com
